PDL BIOPHARMA, INC.·4

Dec 4, 9:17 PM ET

Stone Christopher Lewis 4

4 · PDL BIOPHARMA, INC. · Filed Dec 4, 2020

Insider Transaction Report

Form 4
Period: 2020-12-02
Stone Christopher Lewis
VP and General Counsel
Transactions
  • Disposition to Issuer

    Common stock

    2020-12-0211,544605,559 total
Footnotes (1)
  • [F1]Disposition of a portion of a restricted stock award due to performance criteria not being achieved under equity incentive plans.

Documents

1 file
  • 4
    wf-form4_160713463756912.xmlPrimary

    FORM 4